Town Hall: Are Symptoms Worth the Money Without Hard Outcomes?
Presenter
Michael J. Rinaldi, M.D., FSCAI, Sanger Heart & Vascular Institute, Charlotte, NC
Michael J. Rinaldi, M.D., FSCAI, Sanger Heart & Vascular Institute, Charlotte, NC
Learning Objectives:
- Review the data on value of tricuspid interventions in absence of a mortality benefit
- Debate the value of symptom-driven interventions in the absence of long-term outcome data.
- Examine cost-effectiveness and quality-of-life metrics in TR treatment decisions.